| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.065 | 0.3 |